A sterile implantable device intended to help prevent dislocation of a total hip replacement by augmenting the posterior lip of the acetabulum around a retained acetabular prosthesis, or to help fill bone defects not covered by the acetabular prosthesis. It is
| Company | Devices | Share |
|---|---|---|
| Medacta International Sa | 49 | 34% |
| Smith & Nephew, Inc. | 41 | 28% |
| Waldemar Link Gmbh & Co. Kg | 26 | 18% |
| Depuy (Ireland) | 24 | 17% |
| Maxx Orthopedics, Inc. | 4 | 3% |
Company = labeler of record on GUDID. 5 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| LPH | PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, POROUS UNC | 114 |
| MEH | Prosthesis, Hip, Semi-Constrained, Uncemented, Metal / Polym | 26 |
| LPH | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Unc | 26 |
| LZO | Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Ce | 26 |
| JWH | PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEM | 24 |
| KRO | PROSTHESIS, KNEE, FEMOROTIBIAL, CONSTRAINED, CEMENTED, METAL | 24 |
Use these as the dimensions to specify in a tender line.
144 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Acetabular augmentation implant", from 5 companies. The largest labeler is Medacta International Sa with 34% of records.
LPH (PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, POROUS UNC), MEH (Prosthesis, Hip, Semi-Constrained, Uncemented, Metal / Polym), LPH (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Unc), LZO (Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Ce)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add acetabular augmentation implant to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.